Nanobots Therapeutics successfully closes a Pre-Seed funding round of €478,000 [22-09-2023]
The start-up specializes in the development of biocompatible nanorobots capable of delivering drugs to difficult-to-treat tumors more efficiently and safely than current therapies. Nanobots Therapeutics is the third investment in the fifth edition of Banco Sabadell’s BStartup Health program, which received applications from 127 start-ups.
🚀 The Quantum Catalogue is now live! Discover 100+ key players in #QuantumTech 🌐 Printed edition QUANTUMatter2025 (May 20–23 | Grenoble) Great visibility for companies, investors & collaborators 🗓️ Submit your info by April 21, 2025 💼 Register for free: https://t.co/1PEZKFEb37pic.twitter.com/btZOB6AuHe
— QUANTUM MATTER CONFERENCE (@QuantumConf) April 16, 2025
